102 related articles for article (PubMed ID: 26429186)
21. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
22. The Diagnostic Utility of PAX8 for Neuroendocrine Tumors: An Immunohistochemical Reappraisal.
Liau JY; Tsai JH; Jeng YM; Kuo KT; Huang HY; Liang CW; Yang CY
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):57-63. PubMed ID: 25710581
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine carcinoma of the urinary bladder. 15-year retrospective analysis.
Perán Teruel M; Giménez Bachs JM; Martínez Ruiz J; Fernández Anguita PJ; Nuñez Sarrión MA; Pastor Guzmán JM; Salinas Sánchez AS; Lorenzo Romero JG; Donate Moreno MJ; Atienzar Tobarra M; Virseda Rodríguez JA
Arch Esp Urol; 2012 Mar; 65(2):237-43. PubMed ID: 22414452
[TBL] [Abstract][Full Text] [Related]
24. [Bone metastasis of leiomyosarcoma. Apropos of a case].
Mariconda M; Tacchetti C; Misiti CM; Lotti G; Ammendolia A; Millo R; Milano C
Rev Chir Orthop Reparatrice Appar Mot; 1995; 81(4):338-43. PubMed ID: 8560004
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of neuroendocrine tumors of the digestive tract].
Wada I; Shimizu N; Seto Y
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1606-10. PubMed ID: 19838017
[TBL] [Abstract][Full Text] [Related]
26. Metastases to soft tissue: a review of 118 cases over a 30-year period.
Plaza JA; Perez-Montiel D; Mayerson J; Morrison C; Suster S
Cancer; 2008 Jan; 112(1):193-203. PubMed ID: 18040999
[TBL] [Abstract][Full Text] [Related]
27. [The clinical characteristic of 43 cases of neuroendocrine tumors with liver metastases].
Li P; Yang XO; Qian JM
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):289-93. PubMed ID: 22781949
[TBL] [Abstract][Full Text] [Related]
28. Additional information gained by positron emission tomography with (68)Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors.
Nakamoto Y; Sano K; Ishimori T; Ueda M; Temma T; Saji H; Togashi K
Ann Nucl Med; 2015 Jul; 29(6):512-8. PubMed ID: 25894056
[TBL] [Abstract][Full Text] [Related]
29. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
[TBL] [Abstract][Full Text] [Related]
30. Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors.
Weksler B; Holden A; Sullivan JL
J Thorac Oncol; 2015 Nov; 10(11):1642-7. PubMed ID: 26317915
[TBL] [Abstract][Full Text] [Related]
31. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
[TBL] [Abstract][Full Text] [Related]
32. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
Imperiale A; Rust E; Gabriel S; Detour J; Goichot B; Duclos B; Kurtz JE; Bachellier P; Namer IJ; Taïeb D
J Nucl Med; 2014 Mar; 55(3):367-72. PubMed ID: 24343986
[TBL] [Abstract][Full Text] [Related]
33. Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
Becherer A; Szabó M; Karanikas G; Wunderbaldinger P; Angelberger P; Raderer M; Kurtaran A; Dudczak R; Kletter K
J Nucl Med; 2004 Jul; 45(7):1161-7. PubMed ID: 15235062
[TBL] [Abstract][Full Text] [Related]
34. A unique retrorectal tumor with neuroendocrine differentiation: case report and review of the literature.
Misawa S; Horie H; Yamaguchi T; Kobayashi S; Kumano H; Lefor AT; Yasuda Y
Int J Surg Pathol; 2013 Jun; 21(3):271-7. PubMed ID: 23486765
[TBL] [Abstract][Full Text] [Related]
35. CT evaluation of gastroenteric neuroendocrine tumors: relationship between ct features and the pathologic classification.
Feng ST; Luo Y; Chan T; Peng Z; Chen J; Chen M; Li ZP
AJR Am J Roentgenol; 2014 Sep; 203(3):W260-6. PubMed ID: 25148182
[TBL] [Abstract][Full Text] [Related]
36. [Neuroendocrine neoplasm of digestive system with different grades: a clinicopathologic and prognostic study].
Zhang MH; Liu YH; Luo XL; Lin XT; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):448-51. PubMed ID: 22932454
[TBL] [Abstract][Full Text] [Related]
37. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine tumours of the digestive tract report of two cases and literature review.
Nouira R; Janabi I; Ben Achour J; Guesmi F; Hani MA; Cherif A; Daghfous M; Bouasker I; Zribi R; Ben Osman S; Zoghlami A; Najah N
Tunis Med; 2003 Jul; 81(7):505-9. PubMed ID: 14534963
[TBL] [Abstract][Full Text] [Related]
39. Ossifying fibromyxoid tumor: report of a case with cytomorphologic description.
Ahmed OI; Qasem SA; Salih ZT
Diagn Cytopathol; 2015 Aug; 43(8):646-9. PubMed ID: 25914177
[TBL] [Abstract][Full Text] [Related]
40. Surgical treatment of neuroendocrine tumors of the lung.
Daddi N; Ferolla P; Urbani M; Semeraro A; Avenia N; Ribacchi R; Puma F; Daddi G
Eur J Cardiothorac Surg; 2004 Oct; 26(4):813-7. PubMed ID: 15450578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
